Abstract:Objectives: To investigate whether lycium barbarum polysaccharides (LBPs) can have a protective effect by regulating Th subsets differentiation in the pathogenesis of ulcerative colitis (UC), which manifests the imbalance of Th subsets.Methods: Dextran sulfate sodium (DSS) mice model was induced in C57BL/6 mice at age of 6-8 weeks in four cycles (i.e., Day0 to Day56) by supplementing DSS in drinking water for 7 days, followed by 7 days of remission to mimic chronic colitis.LBPs were administrated via gavage during the whole induction period.The protective effect of LBPs was evaluated characterized by body weight gain, DAI score, colon length shortening, HE scores and MPO.The percentage of Th subsets was assessed in peripheral blood mononuclear cells (PBMCs) and lamina propria mononuclear cells (LPMCs) from mice by flow cytometry analysis.The Th cytokine profiles were measured by Real-time-PCR(RT-PCR) and ELISA.Peripheral blood CD4 + T were isolated from UC patients in active/remission phase and healthy volunteers.The effect of LBPs activation on Th subsets differentiation was investigated and analyzed by flow cytometry in vitro.Results: The profiles of body weight gain, DAI score, colon length shortening, HE scores and MPO ameliorated after LBPs administration (P s <0.05).The increased percentage of Th1 and Th2 cells in DSS group dropped sharply in PBMCs and LPMCs from mice model after LBPs supplementation.The production of Th1 cytokine profiles (IFN-g, T-b, TNF-a) was inhibited measured by RT-PCR and ELISA(P s <0.05).CD4 + T cells from acute UC patients (A-UC) and UC patients in remission(R-UC) has illustrated a higher level of IL-4 + CD4 + T cells compared to the Healthy-control group.Once activation with LBPs, the high level of IL-4 + CD4 + T cells lowered both in A-UC and R-UC groups.Meanwhile, low level of IFN-g + CD4 +T cells markedly increased in A-UC and R-UC group after LBPs activation.Furthermore, the low level of Th1/Th2 in A-UC and R-UC group got higher after activation with LBPs.Conclusion: Our data reveal a novel finding that LBPs can inhibit the capability of CD4 + T cells in the induction of colitis and restore the healthy balance of Th subsets, thus contributing to the maintenance of intestinal homeostasis.In the future, LBPs may serve as a novel therapeutic approach to restore the aberrant immune responses for inducing the remission of UC.

An arabinogalactan from Lycium barbarum attenuates DSS-induced chronic colitis in C57BL/6J mice associated with the modulation of intestinal barrier function and gut microbiota

An arabinogalactan from <i>Lycium barbarum</i> attenuates DSS-induced chronic colitis in C57BL/6J mice associated with the modulation of intestinal barrier function and gut microbiota

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

An arabinogalactan from Lycium barbarum mitigated DSS caused intestinal injury via inhibiting mucosal damage and regulating the gut microbiota disorder

Lycium Barbarum Arabinogalactan Alleviates Intestinal Mucosal Damage in Mice by Restoring Intestinal Microbes and Mucin O-glycans

Impact Oflycium Barbarumarabinogalactan on the Fecal Metabolome in a DSS-induced Chronic Colitis Mouse Model

Lycium Barbarum Polysaccharide Remodels Colon Inflammatory Microenvironment and Improves Gut Health

Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota

The Polysaccharides from the Fruits of Lycium Barbarum L. Modify the Gut Community Profile and Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice.

Different Regulatory Effects of Lycium Barbarum Polysaccharide Components on Gut Microbiota in Vivo and in Vitro

Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice

Arbutin alleviates intestinal colitis by regulating neutrophil extracellular traps formation and microbiota composition

Lycium Barbarum Polysaccharide Down-regulates the Expression of IFN-γ in Ulcerative Colitis

Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways

Agaricus blazei Polysaccharide Alleviates DSS-Induced Colitis in Mice by Modulating Intestinal Barrier and Remodeling Metabolism

Sa1114 MODELING CONTEXT-DEPENDENT BUBR1 KINASE SIGNALING USING GASTRIC ORGANOIDS

Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway

Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy

New resource food-arabinogalactan improves DSS-induced acute colitis through intestinal flora and NLRP3 signaling pathway

The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice

Black Lycium barbarum polysaccharide attenuates LPS-induced intestine damage via regulation gut microbiota